The "Global Dengue Vaccine Market 2017-2021" report has been added to Research and Markets' offering. The global dengue vaccine market to grow at a CAGR of 15.05% during the period 2017-2021. Global ...
An experiment to infect mosquitoes with bacteria that stop them from transmitting viruses appears to have helped reduced the spread of deadly dengue virus in Indonesia, researchers reported Wednesday.
A Singapore study led by the Novartis Institute for Tropical Diseases (NITD) has shown that a novel small-molecule inhibitor of the dengue virus (DENV) nonstructural protein 4B (NS4B) has favorable ...
Blocking the interaction between two dengue virus (DENV) nonstructural proteins, NS3 and NS4B, with a newly developed small-molecule inhibitor resulted in potent antiviral activity in mouse models, ...
An expert panel voted Thursday to advise that the Centers for Disease Control and Prevention recommend use of a controversial dengue vaccine, despite the fact that it can only be given to a small ...
(RTTNews) - Janssen Pharmaceuticals, wholly-owned by Johnson & Johnson (JNJ) Wednesday announced that an early-stage compound with a novel mechanism of action showed that it could potentially treat ...
Delhi records highest November malaria cases in four years at 67, while dengue infections see a significant decline.
An experiment to infect mosquitoes with bacteria that stop them from transmitting viruses appears to have helped reduced the spread of deadly dengue virus in Indonesia, researchers reported Wednesday.
An experiment to infect mosquitoes with bacteria that stop them from transmitting viruses appears to have helped reduced the spread of deadly dengue virus in Indonesia, researchers reported Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback